Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

From a shared origin to divergent frames: A computational analysis of media representations of Kampo Medicine and Traditional Chinese Medicine in Asahi Shimbun.

PloS one·2026
Same author

Towards anti-<i>Toxoplasmosis</i> agents: synthesis and biological evaluation of diosgenin ester derivatives.

Natural product research·2026
Same author

Molecular Characterization of T-Lineage Acute Lymphoblastic Leukemia by an Optimal-Transport Based Multi-Omics Integration Framework.

bioRxiv : the preprint server for biology·2026
Same author

Atlas-Level Single-Cell and Spatial Transcriptomics Data Integration via PRIME.

bioRxiv : the preprint server for biology·2026
Same author

Machine learning based on radiomics for discriminating sellar region langerhans cell histiocytosis from germ cell tumors.

Frontiers in pediatrics·2026
Same author

Role of circSRSF1 in apoptosis, inflammation, and macrophage polarization during acute respiratory distress syndrome.

Biochemical and biophysical research communications·2026
Same journal

Targeted Delivery of Indole-3-Pyruvic Acid Suppresses Macrophage Ferroptosis to Enhance CD8<sup>+</sup> T Cell-Mediated Immunotherapy Response in Bladder Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Pathological Copper Overload Reprograms SOD1 Activation via COMMD1 to Promote Senescence and Fibrosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Bending-Resistant Intimate 3D Graphene-Metal Heterojunctions for Highly Sensitive and Robust Flexible Sensors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Pathology-Instructed Theranostic Platform with Mechanoadaptive and ROS-Powered Nanobreathing Functions for Precision Myocardial Repair.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Targeting p21-High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Ceramic Network for Hybrid Solid Electrolyte Lithium Metal Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
查看所有相关文章

相关实验视频

Updated: Feb 26, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.2K

利用人工智能和大型语言模型用于癌症免疫治疗.

Xinchao Wu1, Mengtao Sun1, Lusheng Li1

  • 1Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 25, 2026
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 和机器学习 (ML) 正在通过改善患者分层和生物标志物发现来彻底改变癌症免疫疗法. 这篇评论探讨了人工智能.

关键词:
人工智能的人工智能是人工智能.癌症免疫疗法免疫疗法基础模型的基础模型.机器学习是机器学习.这是一个多主题的多omics.

更多相关视频

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.6K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

相关实验视频

Last Updated: Feb 26, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

5.6K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 人工智能的人工智能

背景情况:

  • 癌症免疫疗法已经推进了瘤治疗,但在预测反应和抵抗方面仍然存在挑战.
  • 人工智能 (AI) 和机器学习 (ML) 为克服这些障碍提供了强大的工具.
  • 现有的深度学习框架,包括大型语言模型 (LLM),在癌症研究中越来越多地使用多omics数据.

研究的目的:

  • 系统地审查和批判性地评估AI/ML在癌症免疫治疗中的应用和翻译潜力.
  • 检查癌症免疫治疗中人工智能的当前发展和未来方向.
  • 为了确定可操作的见解,将AI/ML整合到精确癌症免疫治疗中.

主要方法:

  • 在癌症免疫治疗中AI/ML应用的全面审查.
  • 讨论四个关键领域:患者分层,生物标志物发现,治疗策略优化和基础模型/LLMs.
  • 对当前AI方法的局限性和未来方向的批判性评估.

主要成果:

  • 人工智能/ML应用正在使患者分层和生物标志物发现取得突破.
  • 基金会模型和LLM正在开发,以整合复杂的多omics数据用于癌症免疫治疗.
  • 该审查确定了AI/ML可以加速精确瘤学的进展的关键领域.

结论:

  • 通过应对关键挑战,AI/ML对推进癌症免疫治疗具有重大前景.
  • 对AI/ML的系统评估和战略整合对于实现其全部翻译潜力至关重要.
  • 未来的研究应该集中在克服局限性和开发人工智能驱动精确癌症免疫治疗的路线图上.